biomarkers

In clinical practice differentiating Alzheimer’s from other conditions whose treatment is far different is important.
 

Since the early 2000s cardiac biomarkers have become the cornerstone for diagnosis, risk stratification and therapeutic decision in cardiovascular diseases, specifically NT-proBNP (congestive heart failure) and cardiac troponins (acute coronary syndromes).

Articles in the latest edition of RGA's ReFlections Newsletter include:

• Trends in Respiratory Diseases
• Biomarkers: Can They Add Value? Part 2
• Pediatric Underwriting
• What Does the Continuity of Care Documents Hold for Underwriters?

http://www.rgare.com/knowledgecenter/Documents/ReFlections%20Spring%2020...